| # | Date |
Title Long |
Author |
|
[ 1 ]
|
2009
|
Does animal welfare affect food safety?
|
Voogd, Erika L.
|
|
[ 2 ]
|
2009
|
Welfare phenotyping of genetically-modified mice.
|
Rose, Margaret
|
|
[ 3 ]
|
2008
|
Clinical and Pathologic Features of Cynomolgus Macaques (Macaca fascicularis) Infected with Aerosolized Yersinia pestis.
|
Van Andel, R.
|
|
[ 4 ]
|
2007
|
Organic food worth the price?
|
Schardt, D.
|
|
[ 5 ]
|
2006
|
Examples of reduction, refinement and replacement from the British Home Office Animals Inspectorate.
|
|
|
[ 6 ]
|
2006
|
Refinement of the use of non-human primates in scientific research. III. Refinement of procedures.
|
Rennie, A.E.
|
|
[ 7 ]
|
2005
|
Genetically modified animals in research: an analysis of applications submitted to ethics committees on animal experimentation in Sweden.
|
Nordgren, A.
|
|
[ 8 ]
|
2005
|
Role of a clinical veterinarian in a safety assessment testing facility.
|
Fillman-Holliday, D.
|
|
[ 9 ]
|
2005
|
Three Rs: past, present and future.
|
Russell, W.M.S.
|
|
[ 10 ]
|
2005
|
Using obese mouse models in research: special considerations for IACUC members, animal care technicians, and researchers.
|
Good, D.J.
|
|
[ 11 ]
|
2004
|
How to balance humane endpoints, scientific data collection, and appropriate veterinary interventions in animal studies.
|
Medina, L.V.
|
|
[ 12 ]
|
2004
|
Toward a more humane intracerebral pathogenicity index that does not compromise virus pathogenicity ratings.
|
Trajstman, A.C.
|
|
[ 13 ]
|
2003
|
Assessing pain, suffering and distress in laboratory animals: an RSPCA surey of current practice in the UK.
|
Hawkins, P.
|
|
[ 14 ]
|
2003
|
Dietary phytoestrogens accelerate the time of vaginal opening in immature CD-1 mice.
|
Thigpen, J.E.
|
|
[ 15 ]
|
2002
|
Alternative methods for acute oral toxicity testing: practical guidance for implementation.
|
Rispin, A.
|
|
[ 16 ]
|
2002
|
Alternative methods for the median lethal dose (LD50) test: the up-and-down procedure for acute oral toxicity.
|
Rispin, A.
|
|
[ 17 ]
|
2002
|
Assessment of progress in the use of alternatives in toxicity testing since the publicaton of the report of the second FRAME Toxicity Committee (1991).
|
Combes, R.
|
|
[ 18 ]
|
2002
|
ECVAM's contributions to the implementation of the Three Rs in the production and quality control of biologicals.
|
Halder, M.
|
|
[ 19 ]
|
2002
|
Humane endpoints for laboratory animals used in regulatory testing.
|
Stokes, W.S.
|
|
[ 20 ]
|
2002
|
Identification of hypoglycemia in mice as a surrogate marker of ricin toxicosis.
|
Pincus, S.H.
|
|
[ 21 ]
|
2001
|
Overview of animal models in experimental schistosomiasis and refinements in the use of non-human primates.
|
Farah, I.O.
|
|
[ 22 ]
|
2000
|
Recognition and alleviation of pain and distress in laboratory animals.
|
|
|
[ 23 ]
|
2000
|
Telemetric evaluation of body temperature and physical activity as predictors of mortality in a murine model of staphylococcal enterotoxic shock.
|
Vlach, K.D.
|
|
[ 24 ]
|
1999
|
Evaluation of surrogate markers of impending death in the galactosamine-sensitized murine model of bacterial endotoxemia.
|
Krarup, A.
|
|
[ 25 ]
|
1998
|
Humane endpoints are an objective measure of morbidity in Venezuelan encephalomyelitis virus infection of mice.
|
Wright, A.J.
|
